|
Canadian and Brazilian researchers published an article in the June 2009 Supportive Care in Cancer finding that "one-fifth of cancer patients at the end of life use medications that lack benefit in the short term."
This might be a good time to provide a taxonomy of the medical futility issue. While I focus primarily on medical futility disputes, those are just one subset of the larger class. There are at least four other situations that present problematic futility issues:
In short, adamant surrogates use the threat of litigation to drive the provision of some non-beneficial treatment. But the far bigger driver of non-beneficial treatment is physicians. |
Write a comment:
|